| Identification | Back Directory | [Name]
L-Phenylalaninamide, N-[[[1-[(2,6-dichlorophenyl)methyl]-3-(1-pyrrolidinylmethyl)-1H-indol-5-yl]amino]carbonyl]glycyl-L-lysyl-N-(diphenylmethyl)- | [CAS]
880546-17-8 | [Synonyms]
K14585
K-14585
K 14585
L-Phenylalaninamide, N-[[[1-[(2,6-dichlorophenyl)methyl]-3-(1-pyrrolidinylmethyl)-1H-indol-5-yl]amino]carbonyl]glycyl-L-lysyl-N-(diphenylmethyl)- | [Molecular Formula]
C51H56Cl2N8O4 | [MOL File]
880546-17-8.mol | [Molecular Weight]
915.95 |
| Hazard Information | Back Directory | [Description]
K-14585 is a proteinase-activated receptor 2 antagonist. Pretreatment with K-14585 inhibited PAR(2)-mediated p65 NFkappaB phosphorylation and NFkappaB-DNA binding. K-14585 inhibited SLIGKV-stimulated IL-8 production, but given alone increased IL-8. K-14585 antagonized PAR(2) competitively, resulting in inhibition of PAR(2)-mediated signalling and physiological responses both in vitro and in vivo. K-14585 could be useful in evaluating PAR(2)-mediated biological events and might lead to a new generation of therapeutically useful antagonists. |
|
|